WEBULL
News
WXIBF
5.25
NaN%
--
Weekly Report: what happened at WXIBF last week (0309-0313)?
Weekly Report · 8h ago
Weekly Report: what happened at WXIBF last week (0302-0306)?
Weekly Report · 03/09 09:16
Weekly Report: what happened at WXIBF last week (0223-0227)?
Weekly Report · 03/02 09:16
Weekly Report: what happened at WXIBF last week (0216-0220)?
Weekly Report · 02/23 09:16
Weekly Report: what happened at WXIBF last week (0209-0213)?
Weekly Report · 02/16 09:16
Zhongtai Securities Reaffirms Their Buy Rating on Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 02/14 05:06
Baird Chautauqua International Growth Fund: Q4 2025 Winners, Laggards, Buys & Sells
Seeking Alpha · 02/13 10:45
China Renaissance Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 02/11 05:05
WuXi Biologics Forecasts Strong 2025 Profit Growth on Expanded Services and Efficiency Gains
TipRanks · 02/10 23:38
WuXi Biologics Sets March 24 Board Meeting to Approve 2025 Annual Results
TipRanks · 02/10 23:38
Weekly Report: what happened at WXIBF last week (0202-0206)?
Weekly Report · 02/09 09:16
WuXi Biologics Jumps On Pact With Vertex Pharma For T-Cell Engager In Autoimmune Disease
NASDAQ · 02/03 08:42
Weekly Report: what happened at WXIBF last week (0126-0130)?
Weekly Report · 02/02 09:16
Weekly Report: what happened at WXIBF last week (0119-0123)?
Weekly Report · 01/26 09:16
Weekly Report: what happened at WXIBF last week (0112-0116)?
Weekly Report · 01/19 09:17
CICC Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 01/16 05:06
WuXi Biologics’ Substantial Shareholder to Cut Stake via HK$38.52 Block Trade
TipRanks · 01/15 23:39
Citigroup-Backed HK$4.00 Cash Offer Launched for Wuxi Biologics Shares at 99% Premium
TipRanks · 01/14 15:09
Weekly Report: what happened at WXIBF last week (0105-0109)?
Weekly Report · 01/12 09:17
WuXi Biologics Highlights Strong 2025 Pipeline and Growth Ahead of J.P. Morgan Healthcare Conference
TipRanks · 01/11 11:37
More
Webull provides a variety of real-time WXIBF stock news. You can receive the latest news about Wuxi Bio through multiple platforms. This information may help you make smarter investment decisions.
About WXIBF
WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The Company mainly conducts its business in the domestic and overseas markets.